Medical therapy versus myocardial revascularization in chronic coronary syndrome and stable angina

Coronary artery disease is a leading cause of death in the United States. Angina is encountered frequently in clinical practice. Effective management of patients with coronary artery disease and stable angina should consist of therapy aimed at symptom control and reduction of adverse clinical outcom...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:The American journal of medicine Ročník 124; číslo 8; s. 681
Hlavní autoři: Deedwania, Prakash C, Carbajal, Enrique V
Médium: Journal Article
Jazyk:angličtina
Vydáno: United States 01.08.2011
Témata:
Acetanilides - therapeutic use
Adrenergic beta-Antagonists - therapeutic use
Angina Pectoris - drug therapy
Angina Pectoris - surgery
Angiotensin-Converting Enzyme Inhibitors - therapeutic use
Benzazepines - therapeutic use
Calcium Channel Blockers - therapeutic use
Cardiovascular Agents - adverse effects
Cardiovascular Agents - pharmacology
Cardiovascular Agents - therapeutic use
Coronary Disease - drug therapy
Coronary Disease - surgery
Drug Therapy, Combination
Humans
Hypolipidemic Agents - therapeutic use
Myocardial Revascularization - statistics & numerical data
Myocardial Revascularization - trends
Nitrates - therapeutic use
Piperazines - therapeutic use
Ranolazine
Treatment Outcome
ISSN:1555-7162, 1555-7162
On-line přístup:Zjistit podrobnosti o přístupu
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
Abstract Coronary artery disease is a leading cause of death in the United States. Angina is encountered frequently in clinical practice. Effective management of patients with coronary artery disease and stable angina should consist of therapy aimed at symptom control and reduction of adverse clinical outcomes. Therapeutic options for angina include antianginal drugs: nitrates, beta-blockers, calcium channel blockers, ranolazine, and myocardial revascularization. Recent trials have shown that although revascularization is slightly better in controlling symptoms, optimal medical therapy that includes aggressive risk factor modification is equally effective in reducing the risk of future coronary events and death. On the basis of the available data, it seems appropriate to prescribe optimal medical therapy in most patients with coronary artery disease and stable angina, and reserve myocardial revascularization for selected patients with disabling symptoms despite optimal medical therapy.
AbstractList Coronary artery disease is a leading cause of death in the United States. Angina is encountered frequently in clinical practice. Effective management of patients with coronary artery disease and stable angina should consist of therapy aimed at symptom control and reduction of adverse clinical outcomes. Therapeutic options for angina include antianginal drugs: nitrates, beta-blockers, calcium channel blockers, ranolazine, and myocardial revascularization. Recent trials have shown that although revascularization is slightly better in controlling symptoms, optimal medical therapy that includes aggressive risk factor modification is equally effective in reducing the risk of future coronary events and death. On the basis of the available data, it seems appropriate to prescribe optimal medical therapy in most patients with coronary artery disease and stable angina, and reserve myocardial revascularization for selected patients with disabling symptoms despite optimal medical therapy.Coronary artery disease is a leading cause of death in the United States. Angina is encountered frequently in clinical practice. Effective management of patients with coronary artery disease and stable angina should consist of therapy aimed at symptom control and reduction of adverse clinical outcomes. Therapeutic options for angina include antianginal drugs: nitrates, beta-blockers, calcium channel blockers, ranolazine, and myocardial revascularization. Recent trials have shown that although revascularization is slightly better in controlling symptoms, optimal medical therapy that includes aggressive risk factor modification is equally effective in reducing the risk of future coronary events and death. On the basis of the available data, it seems appropriate to prescribe optimal medical therapy in most patients with coronary artery disease and stable angina, and reserve myocardial revascularization for selected patients with disabling symptoms despite optimal medical therapy.
Coronary artery disease is a leading cause of death in the United States. Angina is encountered frequently in clinical practice. Effective management of patients with coronary artery disease and stable angina should consist of therapy aimed at symptom control and reduction of adverse clinical outcomes. Therapeutic options for angina include antianginal drugs: nitrates, beta-blockers, calcium channel blockers, ranolazine, and myocardial revascularization. Recent trials have shown that although revascularization is slightly better in controlling symptoms, optimal medical therapy that includes aggressive risk factor modification is equally effective in reducing the risk of future coronary events and death. On the basis of the available data, it seems appropriate to prescribe optimal medical therapy in most patients with coronary artery disease and stable angina, and reserve myocardial revascularization for selected patients with disabling symptoms despite optimal medical therapy.
Author Carbajal, Enrique V
Deedwania, Prakash C
Author_xml – sequence: 1
  givenname: Prakash C
  surname: Deedwania
  fullname: Deedwania, Prakash C
  email: deed@fresno.ucsf.edu
  organization: Division of Cardiology, Department of Medicine, Veterans Affairs Central California Health Care System, University of California, San Francisco, School of Medicine, Fresno, USA. deed@fresno.ucsf.edu
– sequence: 2
  givenname: Enrique V
  surname: Carbajal
  fullname: Carbajal, Enrique V
BackLink https://www.ncbi.nlm.nih.gov/pubmed/21787900$$D View this record in MEDLINE/PubMed
BookMark eNpNkF9LwzAUxYNM3B_9BiJ586k1SZcufZThVJj4svdym966jDaZSTuon96IE7wv58A998LvzMnEOouE3HKWcsbzh0MK3aHDOhWM85SJlGX5BZlxKWWy4rmY_PNTMg_hwOIUMr8iU8FXalUwNiPVG9ZGQ0v7PXo4jvSEPgyBdqPT4GsTNx5PEPTQgjdf0BtnqbFU772zRlPtooIfaRht7V2HFGxNQw9V-2M_jIVrctlAG_DmrAuy2zzt1i_J9v35df24TbSUqk845KIR-bIQoqpQqabATEguVVUgKAQmiobnuq4FE0whyxqAeKOWmVS6qMSC3P--PXr3OWDoy84EjW0LFt0Qygi8VFmkjsm7c3KoYoHl0ZsuIpR_rYhvZuNpwQ
CitedBy_id crossref_primary_10_1007_s40265_012_0005_z
crossref_primary_10_1111_eci_12025
crossref_primary_10_1007_s10354_012_0113_0
crossref_primary_10_1093_ehjqcco_qcw024
crossref_primary_10_1148_radiol_12112756
crossref_primary_10_1016_j_mehy_2013_03_033
crossref_primary_10_1155_2016_1384658
crossref_primary_10_1002_clc_21993
crossref_primary_10_4137_CMC_S9132
crossref_primary_10_1016_j_tracli_2021_02_001
crossref_primary_10_1016_j_arcmed_2015_06_001
ContentType Journal Article
Copyright Published by Elsevier Inc.
Copyright_xml – notice: Published by Elsevier Inc.
DBID CGR
CUY
CVF
ECM
EIF
NPM
7X8
DOI 10.1016/j.amjmed.2011.02.036
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: 7X8
  name: MEDLINE - Academic
  url: https://search.proquest.com/medline
  sourceTypes: Aggregation Database
DeliveryMethod no_fulltext_linktorsrc
Discipline Medicine
EISSN 1555-7162
ExternalDocumentID 21787900
Genre Journal Article
Review
GroupedDBID ---
--K
-~X
.-4
.1-
.55
.FO
.GJ
0R~
123
1B1
1CY
1P~
1RT
1~5
23M
3O-
4.4
457
4CK
4G.
53G
5RE
5VS
6J9
7-5
AAEDT
AAEDW
AAFWJ
AALRI
AAQFI
AAQQT
AAQXK
AAWTL
AAXUO
AAYWO
ABLJU
ABMAC
ABOCM
ABPPZ
ABWVN
ACGFO
ACIUM
ACKOT
ACPRK
ACRPL
ACVFH
ADBBV
ADCNI
ADMUD
ADNMO
ADVLN
AENEX
AEUPX
AEVXI
AFCTW
AFFNX
AFHKK
AFJKZ
AFPUW
AFRHN
AFTJW
AGCQF
AGHFR
AGQPQ
AHHHB
AHMBA
AIGII
AITUG
AJUYK
AKBMS
AKRWK
AKYEP
ALMA_UNASSIGNED_HOLDINGS
AMRAJ
APXCP
ASPBG
AVWKF
AZFZN
BELOY
BKOMP
C5W
CGR
CS3
CUY
CVF
EBS
ECM
EFJIC
EFKBS
EIF
EJD
EX3
F5P
FDB
FEDTE
FGOYB
FIRID
G-2
G-Q
GBLVA
HEA
HMK
HMO
HVGLF
HZ~
IH2
IHE
J1W
J5H
K-O
KOM
L7B
LZ2
M29
M41
MO0
MVM
N4W
N9A
NPM
NQ-
O9-
OD.
OHT
OO~
P2P
PC.
PQQKQ
R2-
RIG
ROL
RPZ
SAE
SEL
SES
SSZ
TWZ
UBY
UHB
UHU
UNMZH
UV1
WH7
WOW
WUQ
X7M
XH2
XPP
YFH
YOC
YQJ
YYQ
Z5R
ZGI
ZUP
ZXP
7X8
ID FETCH-LOGICAL-c558t-1a62f264922bbe88f9e325158b9ea8ea029f16cdd20208e03faa1a684358c9b2
IEDL.DBID 7X8
ISICitedReferencesCount 14
ISICitedReferencesURI http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000293010100016&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN 1555-7162
IngestDate Thu Oct 02 06:14:23 EDT 2025
Mon Jul 21 06:04:45 EDT 2025
IsPeerReviewed true
IsScholarly true
Issue 8
Language English
License Published by Elsevier Inc.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c558t-1a62f264922bbe88f9e325158b9ea8ea029f16cdd20208e03faa1a684358c9b2
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
ObjectType-Review-3
content type line 23
PMID 21787900
PQID 879483790
PQPubID 23479
ParticipantIDs proquest_miscellaneous_879483790
pubmed_primary_21787900
PublicationCentury 2000
PublicationDate 2011-08-01
PublicationDateYYYYMMDD 2011-08-01
PublicationDate_xml – month: 08
  year: 2011
  text: 2011-08-01
  day: 01
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle The American journal of medicine
PublicationTitleAlternate Am J Med
PublicationYear 2011
SSID ssj0000956
Score 2.1070154
SecondaryResourceType review_article
Snippet Coronary artery disease is a leading cause of death in the United States. Angina is encountered frequently in clinical practice. Effective management of...
SourceID proquest
pubmed
SourceType Aggregation Database
Index Database
StartPage 681
SubjectTerms Acetanilides - therapeutic use
Adrenergic beta-Antagonists - therapeutic use
Angina Pectoris - drug therapy
Angina Pectoris - surgery
Angiotensin-Converting Enzyme Inhibitors - therapeutic use
Benzazepines - therapeutic use
Calcium Channel Blockers - therapeutic use
Cardiovascular Agents - adverse effects
Cardiovascular Agents - pharmacology
Cardiovascular Agents - therapeutic use
Coronary Disease - drug therapy
Coronary Disease - surgery
Drug Therapy, Combination
Humans
Hypolipidemic Agents - therapeutic use
Myocardial Revascularization - statistics & numerical data
Myocardial Revascularization - trends
Nitrates - therapeutic use
Piperazines - therapeutic use
Ranolazine
Treatment Outcome
Title Medical therapy versus myocardial revascularization in chronic coronary syndrome and stable angina
URI https://www.ncbi.nlm.nih.gov/pubmed/21787900
https://www.proquest.com/docview/879483790
Volume 124
WOSCitedRecordID wos000293010100016&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText
inHoldings 1
isFullTextHit
isPrint
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV07T8MwELaAIsTC-1Fe8sBqcJ2XPSGEqBho1aFC3aKz40hFbVqaFqn_nnPiwIQYWKJIiaXIutx95_vuO0JuwcaaQxKxOOSGhdrETILExNVykKYDeVaxKt9ek35fjkZq4Lk5padVNj6xctTZzLgz8nuJhoPJlOIP8w_mhka54qqfoLFJWgEiGWfUyehHLNxp7FVyqVHEnFBS0zlX0btg-o7hxmt4ijsexL9jzCrWdPf_-ZUHZM-DTPpYW8Uh2bDFEdnp-TL6MdG-PEPr7qs1ddyMVUmna4xszmImdGEbjqpv1KTjgppaSZcaJ3sAizVt9A4oFBlFnKkn7taNejghw-7z8OmF-WELzESRXLIOxCJHdKSE0NpKmSsbIPaJpFYWpAUuVN6JTZYJN9bT8iAHwDUS4ZY0SotTslXMCntOaC4B3UiYQKZsmMVaBpLngYUE3xXAZZvQZu9StGVXoIDCzlZl-r17bXJW7386rzU3Usyc8CnnF38vviS7zcEv71yRVo7_sb0m2-ZzOS4XN5WN4LU_6H0BjqzInw
linkProvider ProQuest
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Medical+therapy+versus+myocardial+revascularization+in+chronic+coronary+syndrome+and+stable+angina&rft.jtitle=The+American+journal+of+medicine&rft.au=Deedwania%2C+Prakash+C&rft.au=Carbajal%2C+Enrique+V&rft.date=2011-08-01&rft.eissn=1555-7162&rft.volume=124&rft.issue=8&rft.spage=681&rft_id=info:doi/10.1016%2Fj.amjmed.2011.02.036&rft_id=info%3Apmid%2F21787900&rft_id=info%3Apmid%2F21787900&rft.externalDocID=21787900
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1555-7162&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1555-7162&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1555-7162&client=summon